The Multiple Sclerosis and Neuroinflammation Center at UCSF
UCSF Pediatric Neuro-Immunology and Multiple Sclerosis Program
UCSF Center for Encephalitis & Meningitis
News
Dr. Stephen Hauser has won the 2025 Breakthrough Prize in Life Sciences. Read more here.
Dr. Emmanuelle Waubant has been named President of ACTRIMS. She is the first female present since ACTRIMS was created 29 years ago, the first president from UCSF, and first from the West Coast.
Dr. Michael Wilson has been elected as a member of the American Society for Clinical Investigation and the Association of American Physicians.
Dr. Scott Zamvil is the new editor of Neurology: Neuroimmunology & Neuroinflammation.
Michael Wilson, MD has won the Trailblazer Prize for Clinician-Scientists from the Foundation for the National Institutes of Health.
Jonah Chan, PhD (above) has won the NINDS Landis Award for Outstanding Mentorship.
Editorial in JAMA Neurology
by Ari Green, MD, MCR
Potential Benefits of Early Aggressive Treatment in Multiple Sclerosis
Division of Neuroimmunology
Ahmed Abdelhak, MD
Katerina Akassoglou, PhD
Sergio Baranzini, PhD
Riley Bove, MD, MSc - Director, BRIDGE
Jonah Chan, PhD - Associate Division Chief
Bruce Cree, MD, PhD, MCR
Stephen Fancy, PhD, DVM
Jeffrey Gelfand, MD
Josiah Gerdts, MD
Douglas Goodin, MD
Ari J. Green, MD, MCR - Division Chief
Joanne Guo, MD - Fellowship Director
Sasha Gupta, MD
Stephen L. Hauser, MD - Director, UCSF Weill Institute
Roland Henry, PhD
Jill Hollenbach, PhD, MPH
Jorge Oksenberg, PhD
Lauren Oommen, DO
Nico Papinutto, PhD
Samuel Pleasure, MD, PhD
Joseph Sabatino, MD, PhD
Emmanuelle Waubant, MD, PhD - Director, Pediatric MS Clinic
Michael Wilson, MD
Scott Zamvil, MD, PhD
Incoming Fellows
Gina Chang, MD, MPH
Sumanth Reddy, MD
Olga Manouvakhova, MD
Methma Udawatta, MD
Current Fellows
Leslie Scarffe, MD, PhD
Leah Zuroff, MD
Greer Waldrop, MD, ScM
Carson R. Moseley, MD, PhD
Martineau Louine, MD
Alyssa Nylander, MD, PhD
Research
See our list of individual laboratories in our division to review basic research programs.
Programs Within the Division
- Small Molecule Remyelination - This is a Phase II, Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis - Ari Green, MD and Jonah Chan, PhD.
- ORIGINS - Stephen L. Hauser, MD and Bruce Cree, MD, PhD (co-PIs).
- Clinical Research - Find trials that are open for enrollment.
- Microbiome - Investigating the role of gut bacteria (microbiota) and their genes (microbiome) in multiple sclerosis (MS) - Sergio Baranzini, PhD. Dr. Baranzini also leads the International MS Microbiome Study.
Members of the Bove Lab presenting data on minimal transfer of rituximab into breastmilk of women with MS, offering a possible treatment option to high-risk women in the postpartum period.
Pictured L-R: Drs. Annika Andersen, Kirsten Krysko, and Alice Edwards.